Nitric Oxide Metabolites in Normal Human Pregnancy and Preeclampsia

References

• Lund C J, Donovan J C. Blood volume during pregnancy. Am J Obstet Gynecol 1969; 98: 393–8
   Google Scholar
• Clark S L, Cotton D B, Lee W, Bishop C, Hill T, Southwick J, et al. Central hemodynamic assessment of normal term pregnancy. Am J Obstet Gynecol 1989; 161: 1439–42
   PubMed Web of Science ®Google Scholar
• Wilson M, Morganti A A, Zervoudakis I, Letcher R L, Romney R M, Von Oeyon P, et al. Blood pressure, the renin‐aldosterone system, and sex steroids throughout normal pregnancy. Am J Med 1980; 68: 97–104
   PubMed Web of Science ®Google Scholar
• Dolezal A, Figor S. The phenomenon of reactive vasodilatation in pregnancy. Am J Obstet Gynecol 1965; 93: 1137–42
   PubMedGoogle Scholar
• Gant N F, Daley G L, Chand S, Whalley P J, Macdonald P C. A study of angiotensin II pressor response throughout primigravid pregnancy. J Clin Invest 1973; 52: 2682–9
   PubMed Web of Science ®Google Scholar
• Cooper D W, Brennecke S P, Wilton A N. Genetics of pre‐eclampsia. Hypertension Preg 1993; 12: 1–23
   Web of Science ®Google Scholar
• Cotton D B, Lee W, Huhta J C, Dorman K F. Hemodynamic profile of severe pregnancy‐induced hypertension. Am J Obstet Gynecol 1988; 158: 523–9
   PubMed Web of Science ®Google Scholar
• Kraayenbrink A A, Dekker G A, van Kamp G J, van Geijn H P. Endothelial vasoactive mediators in preeclampsia. Am J Obstet Gynecol 1993; 169: 160–5
   PubMed Web of Science ®Google Scholar
• Rodgers G M, Taylor R N, Roberts J M. Pre‐eclampsia is associated with a serum factor cytotoxic to human endothelial cells. Am J Obstet Gynecol 1989; 159: 908–14
   Google Scholar
• Roberts J M, Taylor R N, Musci T J, Rodgers G M, Hubel C A, McLaughlin M K. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 1989; 161: 1200–4
   PubMed Web of Science ®Google Scholar
• Palmer R M J, Ashton D S, Moncada S. Vascular endothelial cells synthesise nitric oxide from L‐arginine. Nature 1988; 333: 664–6
   PubMed Web of Science ®Google Scholar
• Vallance P, Collier J, Moncada S. Effects of endothelium‐derived nitric oxide on peripheral arteriolar tone in man. Lancet 1989; 2: 997–1000
   PubMed Web of Science ®Google Scholar
• Weiner C, Martinez E, Zhu L K, Ghodsi A, Chestnut D. In vitro release of endothelium‐derived relaxing factor by acetylcholine is increased during the guinea‐pig pregnancy. Am J Obstet Gynecol 1989; 161: 1599–1605
   PubMed Web of Science ®Google Scholar
• Panza J A, Quyyumi A A, Brush J E, Epstein S E. Abnormal endothelium‐dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990; 323: 22–7
   PubMed Web of Science ®Google Scholar
• Panza J A, Casino P R, Kilcoyne C M, Quyyumi A A. Role of endothelium‐derived nitric oxide in the abnormal endothelium‐dependent vascular relaxation of patients with essential hypertension. Circulation 1993; 87: 1468–74
   PubMed Web of Science ®Google Scholar
• Rapoport R M, Murad F. Agonist induced endothelium‐dependent relaxation in rat thoracic aorta may be mediated through cyclic GMP. Circ Res 1983; 52: 352–7
   PubMed Web of Science ®Google Scholar
• Wennmalm Å, Benthin G, Edlund A, Jungersten L, Kieler‐Jensen N, Lundin S, et al. Metabolism and excretion of nitric oxide in humans: an experimental and clinical study. Circ Res 1993; 73: 1121–7
   PubMed Web of Science ®Google Scholar
• Kanno K, Hirata Y, Emori T, Ohta K, Eguchi S, Imai T, et al. L‐arginine infusion induces hypotension and diuresis/natriuresis with concomitant increased urinary excretion of nitrite/nitrate and cyclic GMP in humans. Clin Exp Pharmacol Physiol 1992; 19: 619–25
   PubMed Web of Science ®Google Scholar
• Hishikawa K, Nakaki T, Suzuki H, Kato R, Saruta T. Role of L‐arginine‐nitric oxide pathway in hypertension. J Hypertension 1993; 11: 639–45
   PubMed Web of Science ®Google Scholar
• Hishikawa K, Nakaki T, Tsuda M, Esumi H, Ohshima H, Suzuki H, et al. Effect of systemic L‐arginine administration on hemodynamics and nitric oxide release in man. Jpn Heart J 1992; 33: 41–8
   PubMedGoogle Scholar
• Fickling S A, Williams D, Vallance P, Nussey S S, Whitley G StJ. Plasma concentrations of endogenous inhibitor of nitric oxide synthesis in normal pregnancy and preeclampsia. Lancet [letter] 1993; 342(8865)242–3
   PubMedGoogle Scholar
• Yallampalli G, Garfield R E. Inhibition of nitric oxide synthesis during pregnancy produces signs similar to those of preeclampsia. Am J Obstet Gynecol 1993; 169: 1316–20
   PubMed Web of Science ®Google Scholar
• Conrad K P, Vernier K A. Plasma level, urinary excretion, and metabolic production of cGMP during gestation in rats. Am J Physiol 1989; 257: R847–R853
   PubMedGoogle Scholar
• Conrad K P, Joffe G M, Kruszyna H, Kruszyna R, Rochelle L G, Smith R P. Identification of increased nitric oxide biosynthesis during pregnancy in rats. FASEB J 1993; 7: 566–71
   PubMed Web of Science ®Google Scholar
• Kopp L, Paradiz G, Tucci J R. Urinary excretion of cyclic 3′,5'‐adenosine monophosphate and cyclic 3',5'‐guanosine monophosphate during and after pregnancy. J Clin Endocrinol Metab 1977; 44: 590–4
   PubMed Web of Science ®Google Scholar
• Barton J R, Sibai B M, Ahokas R A, Whybrew D, Mercer B M. Magnesium sulfate therapy in preeclampsia is associated with increased urinary cyclic guanosine monophosphate excretion. Am J Obstet Gynecol 1992; 167: 931–4
   PubMed Web of Science ®Google Scholar
• Pinto A, Sorrentino R, Sorrentino P, Guerritore T, Moranda L, Biondi A, et al. Endothelial‐derived relaxing factor released by endothelial cells of human umbilical vessels and its impairment in pregnancy‐induced hypertension. Am J Obstet Gynecol 1991; 164: 507–13
   PubMed Web of Science ®Google Scholar
• Cortas N K, Wakid N W. Determination of inorganic nitrate in serum and urine by a kinetic cadmium‐reduction method. Clin Chem 1990; 36: 1440–3
   PubMed Web of Science ®Google Scholar
• Bradford M A. A rapid and sensitive method for quantification of microgram quan‐tities of protein utilising the principle of protein‐dye binding. Anal Biochem 1976; 72: 248–54
   PubMed Web of Science ®Google Scholar
• Schneider N R, Yeary R A. Measurement of nitrite and nitrate in blood. Am J Vet Res 1973; 34: 133–5
   PubMedGoogle Scholar
• Hegesh E, Shiloah J. Blood nitrates and infantile methemoglobinemia. Clin Chim Acta 1982; 125: 107–15
   PubMed Web of Science ®Google Scholar
• Florin T H J, Neale G, Cummings J H. The effect of dietary nitrate on nitrate and nitrite excretion in man. Br J Nutrition 1990; 64: 387–97
   PubMedGoogle Scholar
• Dejong P, Burgraaf M. An ion‐chromatographic method for the simultaneous determination of inorganic phosphate, bromide, nitrate, and suphate in human serum. Clin Chim Acta 1983; 132: 63–71
   PubMedGoogle Scholar
• Osterloh J, Goldfield D. Determination of nitrate and nitrite ions in human plasma by ion‐exchange high performance liquid chromatography. J Liq Chromatogr 1984; 7: 753–63
   Web of Science ®Google Scholar
• Wennmalm Å, Benthin G, Petersson A ‐S. Dependence of the metabolism of nitric oxide (NO) in healthy human whole blood on the oxygenation of its red cell haemoglobin. Br J Pharmacol 1992; 106: 507–8
   PubMed Web of Science ®Google Scholar
• Wagner D A, Schultz D S, Deen W M, Young V R, Tannenbaum S. Metabolic fate of an oral dose of l5N‐labeIed nitrate in humans: effect of diet supplementation with ascorbic acid. Cancer Res 1983; 43: 1921–5
   PubMed Web of Science ®Google Scholar
• Moncada S, Palmer R M J, Higgs E A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43: 109–42
   PubMed Web of Science ®Google Scholar
• Ochoa J B, Curti B, Peitzman A B, Simmons R L, Billiar T R, Hoffman R, et al. Increased circulating nitrogen oxides after human tumor immunotherapy: Correlation with toxic hemodynamic changes. J Natl Cancer Inst. 1992; 84: 864–7
   PubMed Web of Science ®Google Scholar
• Kilbourn R G, Gross S S, Lodato R F, Adams J, Levi R, Miller L L, et al. Inhibition of interleukin‐1‐α‐induced nitric oxide synthase in vascular smooth muscle and full reversal of interleukin‐1‐α‐induced hypotension by N‐amino‐L‐arginine. J Natl Cancer Inst 1992; 84: 1008–16
   PubMed Web of Science ®Google Scholar
• Hibbs J B, Westenfelder C, Taintor R, Vavrin Z, Kablitz C, Baranowski R L, et al. Evidence for cytokine inducible nitric oxide synthesis from L‐arginine in patients receiving interleukin‐2 therapy. J Clin Invest 1992; 89: 867–77
   PubMed Web of Science ®Google Scholar
• McCall T B, Palmer R M, Moncada S. Induction of nitric oxide synthase in rat peritoneal neutrophils and its inhibition by dexamethasone. Eur J Immunol 1991; 21: 2523–7
   PubMed Web of Science ®Google Scholar
• Baylis C, Engels K. Adverse interactions between pregnancy and a new model of systemic hypertension produced by chronic blockade of endothelial derived relaxing factor (EDRF) in the rat. Clin Exp Hypertension Preg 1992; Bll: 117–29
   Google Scholar
• Brennecke S P, Dilulio J L, Gude N M, King R G. Nitric oxide synthase activity of preterm human placental tissue is reduced in pre‐eclampsia [abstract]. Placenta 1994; 15: A6
   Google Scholar
• Seligman S P, Buyon J P, Clancy R M, Young B K, Abramson S B. The role of nitric oxide in the pathogenesis of preeclampsia. Am J Obstet Gynecol 1994; 171: 944–8
   PubMed Web of Science ®Google Scholar